Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2000
08/03/2000WO2000044375A1 Antioxidant compositions and methods for companion animals
08/03/2000WO2000044371A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000044348A2 Materials and methods for making improved micelle compositions
08/03/2000WO2000027850A3 Crf receptor antagonists and methods relating thereto
08/03/2000WO2000023471A3 Use of a cytokine-producing lactococcus strain to treat colitis
08/03/2000WO2000023407A3 Ureido-thiobutyric acid derivatives as ppar-agonists
08/03/2000WO2000020421A3 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS
08/03/2000WO2000009551A9 Human chordin-related proteins and polynucleotides encoding them
08/03/2000WO2000008006A3 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000WO2000006185A3 Methods of using lanreotide, a somatostatin analogue
08/03/2000WO2000006146A9 Substituted anilide compounds and methods
08/03/2000WO1999026942A8 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
08/03/2000DE19901921A1 Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels Polymorphs of telmisartan, to processes for their preparation and their use for the preparation of a medicament
08/03/2000CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000CA2360674A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2359994A1 Production of tetravalent antibodies
08/03/2000CA2359034A1 Pyrazino(aza)indole derivatives
08/03/2000CA2359030A1 Substituted phenethylamine derivatives
08/03/2000CA2358964A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
08/03/2000CA2357735A1 Modulation of immune response by ribavirin
08/03/2000CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/03/2000CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000CA2355735A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/03/2000CA2296936A1 Novel core 2 beta-1,6-n-acetylglycosaminyltransferase
08/02/2000EP1024189A1 Novel antigenic class of avian reoviruses
08/02/2000EP1023605A1 Methods and compositions for detecting hepatitis e virus
08/02/2000EP1023445A1 Cadherin derived growth factor and the application thereof
08/02/2000EP1023440A1 Enteric coated microgranules for stabilizing lactic acid bacteria
08/02/2000EP1023323A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
08/02/2000EP1023318A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin
08/02/2000EP1023287A1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors
08/02/2000EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000EP1023282A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors
08/02/2000EP1023273A1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors
08/02/2000EP1023263A1 Novel vitamin d analogues
08/02/2000EP1023084A1 Compositions for controlling bacterial colonization
08/02/2000EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
08/02/2000EP1023080A1 Ligand binding site of rage and uses thereof
08/02/2000EP1023069A1 Nicotine compositions and methods of formulation thereof
08/02/2000EP1023066A1 Novel pyrazole and pyrazoline substituted compounds
08/02/2000EP1023063A1 INDENO 1,2-c]-, NAPHTHO 1,2-c]- AND BENZO 6,7]CYCLOHEPTA 1,2-c]PYRAZOLE DERIVATIVES
08/02/2000EP1023061A1 Somatostatin agonists
08/02/2000EP1023060A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
08/02/2000EP1023049A1 Preparation of a directly mouldable tabletting auxiliary
08/02/2000EP1023037A1 Plaque-inhibiting oral compositions
08/02/2000EP0729325A4 Osteogenic product and process
08/02/2000CN1261888A 2{4-[4-(4,5-dichloro-2-methylimidazol-1-yl) butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and therapeutic use
08/02/2000CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000CN1261882A Polymorphic form of tachykinin receptor antagonist 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl) phenyl) ethoxy)-3-(S)-(4-fluoro) phenyl-4-(3-5(oxo-1H,4H-1,2,4-triazolo methylmorpholine
08/02/2000CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
08/02/2000CN1261800A Method of treatment of lever tumours and pharmaceutical compositions for use therein
08/02/2000CN1261791A Targeted liposomal constructs for diagnostic and therapeutic uses
08/02/2000CN1261537A Recovery powder for heptitis C
08/02/2000CN1055018C Medicinal composition for urcerative celitis
08/02/2000CN1055015C Weijisan for gastropathy
08/02/2000CN1055014C Medicine powder for curing hepatitis B
08/02/2000CN1055010C Traditional Chinese medicine for treatment of gall stone and urinary stone
08/02/2000CN1055003C Medicine for curing calculus in human body
08/02/2000CN1055001C Powder for eliminating infantile malnutriition of child and its prepn. method
08/02/2000CN1054982C Process for preparing Qiangweisan (medicinal powder for invigorating function of stomach)
08/01/2000US6096902 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
08/01/2000US6096885 Exhibit agonist activity for cck-a receptors thereby enabling them to modulate the hormones gastrin and cholecystokinin in mammals.
08/01/2000US6096774 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, intiators and gas generators
08/01/2000US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding
08/01/2000US6096772 Use of Angiotensin II type 1 receptor antagonists in the treatment of dyspeptic symptoms
08/01/2000US6096766 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
08/01/2000US6096758 3-methylimidazopyridines
08/01/2000US6096753 Substituted pyrimidinone and pyridone compounds and methods of use
08/01/2000US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases
08/01/2000US6096739 Treatment for CNS injuries
08/01/2000US6096735 Benzoheterocyclic derivatives
08/01/2000US6096517 Human kidney sodium bicarbonate transporter (HNBC1A) polynucleotides
08/01/2000US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics
08/01/2000US6096340 Omeprazole formulation
08/01/2000US6096319 Peptides with amino acid sequences
08/01/2000CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/01/2000CA2133762C Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
08/01/2000CA2066640C Heterocyclic compounds
07/2000
07/29/2000CA2290771A1 Azithromycin combination for emesis control in dogs
07/27/2000WO2000043498A2 Human liver progenitors
07/27/2000WO2000043495A2 33 human secreted proteins
07/27/2000WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents
07/27/2000WO2000043378A1 New morpholinobenzamide salts
07/27/2000WO2000043373A2 Kinase inhibitors
07/27/2000WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043370A1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
07/27/2000WO2000043362A1 Phenylsulphonyl derivatives as 5-ht receptor ligands
07/27/2000WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery
1 ... 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 ... 1258